GAX-CI
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GAX-CI, covering 2025-12-04 to 2025-12-04. Get the full timeline:
Most recent: Clinical Trial Update: Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer. [Phase 2]